Health
RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis…
RedHill Biopharma Ltd. (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.
Acting rapidly to ensure emergency transport and supply of drug, treatment was initiated with orally-administered opaganib within the past week. Opaganib is a novel, orally-administered sphingosine kinase-2 (SK2)…
-
Business16 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General13 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General23 hours agoAustralia solved civilisation’s problems
-
Business21 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035